iNtRON Biotechnology develops antibacterial drugs targeting MRSA (Methicillin Resistant Staphylococcus Aureus), as well as other prevalent antibiotic resistant bacteria
Based on its world-class bacteriophage (bacteria killing) technology, the company plans to roll-out series of novel antibiotics